(Q43831827)

27 November 2017

title

The bivariate continual reassessment method. extending the CRM to phase I trials of two competing outcomes (English)

1 reference

27 November 2017

main subject

phase I clinical trial

0 references

author name string

Thomas M Braun

series ordinal

1

1 reference

27 November 2017

language of work or name

English

0 references

publication date

1 June 2002

1 reference

Contemporary Clinical Trials

27 November 2017

published in

1 reference

27 November 2017

volume

23

1 reference

27 November 2017

issue

3

1 reference

27 November 2017

page(s)

240-256

1 reference

Continual reassessment method: a practical design for phase 1 clinical trials in cancer.

27 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0197-2456%2801%2900205-7

7 January 2021

Design and analysis of phase I clinical trials

1 reference

https://api.crossref.org/works/10.1016%2FS0197-2456%2801%2900205-7

7 January 2021

Cancer phase I clinical trials: efficient dose escalation with overdose control.

1 reference

https://api.crossref.org/works/10.1016%2FS0197-2456%2801%2900205-7

7 January 2021

A curve-free method for phase I clinical trials.

1 reference

https://api.crossref.org/works/10.1016%2FS0197-2456%2801%2900205-7

7 January 2021

Isotonic designs for phase I trials

1 reference

https://api.crossref.org/works/10.1016%2FS0197-2456%2801%2900205-7

7 January 2021

A strategy for dose-finding and safety monitoring based on efficacy and adverse outcomes in phase I/II clinical trials.

1 reference

https://api.crossref.org/works/10.1016%2FS0197-2456%2801%2900205-7

7 January 2021

A new statistical method for dose-finding based on efficacy and toxicity in early phase clinical trials

1 reference

https://api.crossref.org/works/10.1016%2FS0197-2456%2801%2900205-7

7 January 2021

Simulation as a design tool for phase I/II clinical trials: an example from bone marrow transplantation.

1 reference

https://api.crossref.org/works/10.1016%2FS0197-2456%2801%2900205-7

7 January 2021

Methods for dose finding studies in cancer clinical trials: a review and results of a Monte Carlo study

1 reference

https://api.crossref.org/works/10.1016%2FS0197-2456%2801%2900205-7

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0197-2456%2801%2900205-7

7 January 2021

Continual reassessment method: a likelihood approach.

1 reference

https://api.crossref.org/works/10.1016%2FS0197-2456%2801%2900205-7

7 January 2021

Models for longitudinal data: a generalized estimating equation approach

1 reference

https://api.crossref.org/works/10.1016%2FS0197-2456%2801%2900205-7

7 January 2021

Modelling multivariate binary data with alternating logistic regressions

1 reference

https://api.crossref.org/works/10.1016%2FS0197-2456%2801%2900205-7

7 January 2021

Sequential designs for phase I clinical trials with late-onset toxicities

1 reference

https://api.crossref.org/works/10.1016%2FS0197-2456%2801%2900205-7

7 January 2021

10.1016/S0197-2456(01)00205-7

Identifiers

DOI

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/5bqbzqn4ezfrzklzeqawtg6mlm

30 July 2022

mapped directly with Wikidata item

Fatcat ID

release_5bqbzqn4ezfrzklzeqawtg6mlm

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/5bqbzqn4ezfrzklzeqawtg6mlm

30 July 2022

mapped directly with Wikidata item

https://api.fatcat.wiki/v0/release/5bqbzqn4ezfrzklzeqawtg6mlm

1 reference

30 July 2022